Xue Wang

3.4k total citations · 1 hit paper
124 papers, 2.1k citations indexed

About

Xue Wang is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xue Wang has authored 124 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Molecular Biology, 40 papers in Oncology and 31 papers in Cancer Research. Recurrent topics in Xue Wang's work include Cancer-related molecular mechanisms research (23 papers), Cancer Immunotherapy and Biomarkers (13 papers) and RNA modifications and cancer (13 papers). Xue Wang is often cited by papers focused on Cancer-related molecular mechanisms research (23 papers), Cancer Immunotherapy and Biomarkers (13 papers) and RNA modifications and cancer (13 papers). Xue Wang collaborates with scholars based in China, United States and France. Xue Wang's co-authors include Xiangju Meng, Mark E. Cohen, Kristopher M. Huffman, Karen Richards, Warren B. Chow, Ryan P. Merkow, Justin B. Dimick, Karl Y. Bilimoria, Lynn Zhou and Clifford Y. Ko and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Xue Wang

114 papers receiving 2.1k citations

Hit Papers

Optimizing ACS NSQIP Modeling for Evaluation of Surgical ... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Wang China 26 724 634 484 399 383 124 2.1k
Hong Zhang China 27 858 1.2× 591 0.9× 380 0.8× 724 1.8× 301 0.8× 214 2.9k
Dawei Wu China 26 527 0.7× 681 1.1× 250 0.5× 491 1.2× 486 1.3× 111 2.1k
Manisha Bhutani United States 27 1.0k 1.4× 1.3k 2.1× 250 0.5× 300 0.8× 345 0.9× 144 2.8k
Ole Thorlacius‐Ussing Denmark 31 602 0.8× 1.0k 1.6× 571 1.2× 390 1.0× 975 2.5× 168 3.2k
G. Ferretti Italy 30 690 1.0× 1.2k 1.9× 579 1.2× 512 1.3× 258 0.7× 150 2.7k
Bonnie Lau United States 16 455 0.6× 337 0.5× 270 0.6× 188 0.5× 215 0.6× 34 1.8k
John Sukumar Aluru United States 9 615 0.8× 604 1.0× 230 0.5× 460 1.2× 540 1.4× 12 1.9k
Patrick Nicolas France 23 707 1.0× 1.2k 1.8× 389 0.8× 576 1.4× 513 1.3× 75 3.0k
Dimitrios Dimitroulis Greece 25 727 1.0× 508 0.8× 272 0.6× 538 1.3× 1.0k 2.6× 177 2.7k
Konstantinos Kontzoglou Greece 28 835 1.2× 641 1.0× 422 0.9× 449 1.1× 761 2.0× 138 2.7k

Countries citing papers authored by Xue Wang

Since Specialization
Citations

This map shows the geographic impact of Xue Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Wang more than expected).

Fields of papers citing papers by Xue Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Wang. The network helps show where Xue Wang may publish in the future.

Co-authorship network of co-authors of Xue Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Wang. A scholar is included among the top collaborators of Xue Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Wang. Xue Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Jing, Dan Du, Xue Wang, et al.. (2025). Deciphering the secret codes in N7‐methylguanosine modification: Context‐dependent function of methyltransferase‐like 1 in human diseases. Clinical and Translational Medicine. 15(2). e70240–e70240. 3 indexed citations
2.
Rivera, Michael, Asha Nair, Yi Liu, et al.. (2024). BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppression. Frontiers in Endocrinology. 15. 1440722–1440722.
3.
Wang, Jiali, et al.. (2024). Network Pharmacology-Based Strategy to Explore the Effect and Mechanism of Zhizhu Granule Improving Glucose-Lipid Metabolism in Rats with Metabolic Syndrome. Diabetes Metabolic Syndrome and Obesity. Volume 17. 3833–3846. 1 indexed citations
6.
Jiang, Xin, et al.. (2023). Classic biphasic pulmonary blastoma: A case report and review of the literature from 2000 to 2022. The Clinical Respiratory Journal. 17(11). 1103–1116. 1 indexed citations
7.
Wang, Xue, et al.. (2023). Advance of immune checkpoint inhibitors in CNS disease. 2(3). 2 indexed citations
9.
Miao, Xin, Gilbert Koch, Shichen Shen, et al.. (2023). Systems Pharmacodynamic Model of Combined Gemcitabine and Trabectedin in Pancreatic Cancer Cells. Part II: Cell Cycle, DNA Damage Response, and Apoptosis Pathways. Journal of Pharmaceutical Sciences. 113(1). 235–245. 3 indexed citations
10.
Tian, Qiuyue, Adam A. Dmytriw, Robert W. Regenhardt, et al.. (2022). Outcomes after endovascular thrombectomy for acute ischemic stroke patients with active cancer: A systematic review and meta-analysis. Frontiers in Neurology. 13. 992825–992825. 5 indexed citations
11.
Wang, Ling, et al.. (2022). Acupuncture for Subthreshold Depression: Study Protocol for a Randomized Controlled Trial. Frontiers in Psychiatry. 12. 772360–772360. 4 indexed citations
12.
Luo, Jichang, Xue Wang, Wei Li, et al.. (2022). PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials. BMJ Open. 12(11). e062046–e062046. 6 indexed citations
13.
Carter, Jodi M., Mei‐Yin C. Polley, Roberto A. Leon‐Ferre, et al.. (2021). Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer. Clinical Cancer Research. 27(20). 5628–5637. 35 indexed citations
14.
Wang, Xue, Chundi Gao, Fubin Feng, et al.. (2020). Construction and Analysis of Competing Endogenous RNA Networks for Breast Cancer Based on TCGA Dataset. BioMed Research International. 2020(1). 4078596–4078596. 14 indexed citations
15.
Wei, Yingying, Xue Wang, Daojun Lv, et al.. (2019). Dynamic Changes of DNA Methylation and Transcriptome Expression in Porcine Ovaries during Aging. BioMed Research International. 2019. 1–15. 11 indexed citations
16.
Ye, Hui, Xue Wang, Lei Wang, et al.. (2019). Full high-throughput sequencing analysis of differences in expression profiles of long noncoding RNAs and their mechanisms of action in systemic lupus erythematosus. Arthritis Research & Therapy. 21(1). 70–70. 37 indexed citations
17.
Zhang, Huijuan, et al.. (2019). Nanocomposite interpenetrating hydrogels with high toughness and good self-recovery. Colloid & Polymer Science. 297(6). 821–830. 11 indexed citations
18.
Wang, Xue, et al.. (2018). The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ. Acta Pharmaceutica. 69(1). 111–119. 23 indexed citations
19.
Fang, Zejun, Chaoju Gong, Weihua Zhou, et al.. (2017). NFYB-induced high expression of E2F1 contributes to oxaliplatin resistance in colorectal cancer via the enhancement of CHK1 signaling. Cancer Letters. 415. 58–72. 56 indexed citations
20.
Li, Han, Qian Li, Su Liu, et al.. (2017). Peripheral blood absolute lymphocyte count, absolute monocyte count and their ratio in prognosis prediction of newly diagnosed multiple myeloma. Tumori. 37(8). 865–872. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026